2-[[5-[2-(4-methoxyphenyl)quinolin-4-yl]-4-phenyl-1,2,4-triazol-3-yl]sulfanyl]-1-phenylethanone
C32H24N4O2S — CID 155810451
Data last refreshed: (MolForge compound catalog, from PubChem)
About 2-[[5-[2-(4-methoxyphenyl)quinolin-4-yl]-4-phenyl-1,2,4-triazol-3-yl]sulfanyl]-1-phenylethanone
2-[[5-[2-(4-methoxyphenyl)quinolin-4-yl]-4-phenyl-1,2,4-triazol-3-yl]sulfanyl]-1-phenylethanone (PubChem CID 155810451) has the molecular formula C32H24N4O2S and a molecular weight of 528.64 g/mol. Its IUPAC name is 2-[[5-[2-(4-methoxyphenyl)quinolin-4-yl]-4-phenyl-1,2,4-triazol-3-yl]sulfanyl]-1-phenylethanone.
Molecular Properties
| Compound Name | 2-[[5-[2-(4-methoxyphenyl)quinolin-4-yl]-4-phenyl-1,2,4-triazol-3-yl]sulfanyl]-1-phenylethanone |
|---|---|
| PubChem CID | 155810451 |
| Molecular Formula | C32H24N4O2S |
| Molecular Weight | 528.64 g/mol |
| Exact Mass | 528.16 |
| IUPAC Name | 2-[[5-[2-(4-methoxyphenyl)quinolin-4-yl]-4-phenyl-1,2,4-triazol-3-yl]sulfanyl]-1-phenylethanone |
| SMILES | COc1ccc(-c2cc(-c3nnc(SCC(=O)c4ccccc4)n3-c3ccccc3)c3ccccc3n2)cc1 |
| InChI | InChI=1S/C32H24N4O2S/c1-38-25-18-16-22(17-19-25)29-20-27(26-14-8-9-15-28(26)33-29)31-34-35-32(36(31)24-12-6-3-7-13-24)39-21-30(37)23-10-4-2-5-11-23/h2-20H,21H2,1H3 |
| InChIKey | XRWLHKPZOCIAMR-UHFFFAOYSA-N |
| XLogP | 7.13 |
| TPSA | 69.90 Ų |
| H-Bond Donors | |
| H-Bond Acceptors | 7 |
| Rotatable Bonds | 8 |
| Heavy Atoms | 39 |
| Complexity | — |
Lipinski Rule of Five
2 violations
| Rule | Value |
|---|---|
| MW ≤ 500 | 528.64 |
| LogP ≤ 5 | 7.13 |
| H-Bond Donors ≤ 5 | 0 |
| H-Bond Acceptors ≤ 10 | 7 |
Frequently Asked Questions
Browse: Molecules A–Z · all molecules A–Z · drugs A–Z · protein targets A–Z.
Sources
- PubChem CID 155810451 — identifiers, structure, computed properties (public domain)
How this page is built: methodology · editorial policy & corrections.
For research and educational use only — not medical advice. This page is compiled automatically from public databases. It is not written or reviewed by a clinician. Do not start, stop or change any treatment based on it; consult a qualified healthcare professional. Spotted an error? See our corrections policy or email hello@molforge.ai.